S&P 500 · Health Care · USD · FY end 2025-12-31
Vertex Pharmaceuticals (VRTX) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 12.00B | 3.95B | 15.32 | 3.19B |
| FY2024 | 11.02B | -535.60M | -2.08 | -790.30M |
| FY2023 | 9.87B | 3.62B | 13.89 | 3.34B |
| FY2022 | 8.93B | 3.32B | 12.82 | 3.93B |
| FY2021 | 7.57B | 2.34B | 9.01 | 2.41B |